PATOGEN AS

PatoGen AS - a fish health company

PatoGen has a long standing record within fish health and has a lasting ambition to be a major contributor to more sustainable production of fish.

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: JU
Jørn Ulheim1969
Chairman of the board: HE
Håvard Selby Ebbestad1959
Years since formation: 21 years; since Mar 24, 2003
Type: Limited company
VAT registered: Yes
Number of employees: 53

Ownership

Number of shares and share classes: 666,667; 1 share class
Total number of shareholders: 1; company
Belongs to group of

Financials

Total operating income 2023: 105,982,758; NOK
Annual total result 2023: 12,107,999; NOK
Total equity 2023: 40,552,365; NOK

Last update: Sep 12, 2024

Management

Management / administration

Name	Role	Shares
JU Jørn Ulheim 1969	Managing Director/CEO	-

Board

Name	Role	Shares
HE Håvard Selby Ebbestad 1959	Chairman	-
VV Vidar Vegsundvåg 1981	Board Member	-
TR Torstein Rikter-Svendsen 1986	Board Member	-
HT Henrik Brenna Tenfjord 1983	Board Member	-
CP Caroline Pedersen 1995	Alternate Member	-
LK Linda Kristin Stavset 1968	Alternate Member	-

Others

Name	Role	Shares
P PKF REVISJON AS	Auditor	-

Last update: Jul 17, 2023

Ownership

Company shareholders

Name	Share class	Number of shares	Share
D DR FURST MEDISINSK LABORATORIUM AS	Ordinary shares	666,667	100 %

Shares owned by the PATOGEN AS

Name	Share class	Number of shares	Share
P PATOGEN NORD AS	Ordinary shares	60	60 %
K KARKANT AS	Ordinary shares	30,000	50 %
N NCE AQUACULTURE AS	Ordinary shares	10	9.09 %

Last update: May 24, 2024

Group structure

LAHO AS
Total operating income 2023: NOK 62,895,043
Operating profit 2023: NOK 53,971,451
Employees: 0

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	105,982,758	93,191,152	90,953,803
Annual Total Result	12,107,999	6,500,784	-4,350,263
Total assets	68,715,935	66,098,868	65,711,562
Total liabilities	28,163,570	19,234,916	25,348,394
Total equity	40,552,365	46,863,952	40,363,168

P&L

Year	2023	2022	2021
Total operating income	105,982,758	93,191,152	90,953,803
Total operating costs	96,123,487	85,064,005	98,805,369
Operating result	9,859,271	8,127,147	-7,851,566
Financial income/costs	1,506,965	4,859	1,616,123
Profit before tax	11,366,236	8,132,006	-6,235,443
Total tax & extraordinary income/cost	-741,763	1,631,222	-1,885,180
Annual Total Result	12,107,999	6,500,784	-4,350,263

Balance overview

Year	2023	2022	2021
Total fixed assets	16,808,296	24,047,713	18,802,858
Total current assets	51,907,639	42,051,155	46,908,704
Total assets	68,715,935	66,098,868	65,711,562
Short term debt	28,163,570	19,234,916	18,067,268
Long term debt	0	0	7,281,126
Total liabilities	28,163,570	19,234,916	25,348,394
Contributed capital	6,904,787	6,904,787	6,904,787
Retained earnings	33,647,578	39,959,165	33,458,381
Total equity	40,552,365	46,863,952	40,363,168
Total equity and liabilities	68,715,935	66,098,868	65,711,562

PATOGEN AS985 525 331

PATOGEN AS

Keywords

Links

Organization

Ownership

Financials

Management

Management / administration

Board

Others

Ownership

Company shareholders

Shares owned by the PATOGEN AS

Group structure

Financials

Summary

P&L

Balance overview

Classification